Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 858

1.

Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms.

Reavis KM, Morris CD, Gopal DV, Hunter JG, Jobe BA.

Ann Surg. 2004 Jun;239(6):849-56; discussion 856-8.

2.

Gastroesophageal reflux disease, proton-pump inhibitor use and Barrett's esophagus in esophageal adenocarcinoma: Trends revisited.

Lada MJ, Nieman DR, Han M, Timratana P, Alsalahi O, Peyre CG, Jones CE, Watson TJ, Peters JH.

Surgery. 2013 Oct;154(4):856-64; discussion 864-6. doi: 10.1016/j.surg.2013.07.020.

PMID:
24074425
3.

Differential response to preoperative chemoradiation and surgery in esophageal adenocarcinomas based on presence of Barrett's esophagus and symptomatic gastroesophageal reflux.

Agarwal B, Swisher SG, Ajani J, Kelly K, Komaki RR, Abu-Hamda E, Correa AM, Roth JA.

Ann Thorac Surg. 2005 May;79(5):1716-23.

PMID:
15854962
4.

Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants.

Dong J, Buas MF, Gharahkhani P, Kendall BJ, Onstad L, Zhao S, Anderson LA, Wu AH, Ye W, Bird NC, Bernstein L, Chow WH, Gammon MD, Liu G, Caldas C, Pharoah PD, Risch HA, Iyer PG, Reid BJ, Hardie LJ, Lagergren J, Shaheen NJ, Corley DA, Fitzgerald RC; Stomach and Oesophageal Cancer Study (SOCS) consortium, Whiteman DC, Vaughan TL, Thrift AP.

Gastroenterology. 2018 Apr;154(5):1273-1281.e3. doi: 10.1053/j.gastro.2017.12.003. Epub 2017 Dec 13.

PMID:
29247777
5.

Symptoms, acid exposure and motility in patients with Barrett's esophagus.

Brandt MG, Darling GE, Miller L.

Can J Surg. 2004 Feb;47(1):47-51.

6.

[The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].

Endzinas Z, Mickevicius A, Kiudelis M.

Zentralbl Chir. 2004 Apr;129(2):99-103. German.

PMID:
15106039
7.

Esophageal adenocarcinoma incidence in individuals with gastroesophageal reflux: synthesis and estimates from population studies.

Rubenstein JH, Scheiman JM, Sadeghi S, Whiteman D, Inadomi JM.

Am J Gastroenterol. 2011 Feb;106(2):254-60. doi: 10.1038/ajg.2010.470. Epub 2010 Dec 7.

8.

Risk factors in the development of esophageal adenocarcinoma.

Pohl H, Wrobel K, Bojarski C, Voderholzer W, Sonnenberg A, Rösch T, Baumgart DC.

Am J Gastroenterol. 2013 Feb;108(2):200-7. doi: 10.1038/ajg.2012.387. Epub 2012 Dec 18.

PMID:
23247577
9.
10.

Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review.

Shaheen N, Ransohoff DF.

JAMA. 2002 Apr 17;287(15):1972-81. Review.

PMID:
11960540
11.

Leukocyte telomere length in relation to the risk of Barrett's esophagus and esophageal adenocarcinoma.

Wennerström EC, Risques RA, Prunkard D, Giffen C, Corley DA, Murray LJ, Whiteman DC, Wu AH, Bernstein L, Ye W, Chow WH, Vaughan TL, Liao LM.

Cancer Med. 2016 Sep;5(9):2657-65. doi: 10.1002/cam4.810. Epub 2016 Jul 6.

12.

Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.

Avidan B, Sonnenberg A, Schnell TG, Chejfec G, Metz A, Sontag SJ.

Am J Gastroenterol. 2002 Aug;97(8):1930-6.

PMID:
12190156
13.

Gender difference in gastro-esophageal reflux diseases.

Asanuma K, Iijima K, Shimosegawa T.

World J Gastroenterol. 2016 Feb 7;22(5):1800-10. doi: 10.3748/wjg.v22.i5.1800. Review.

14.

LOW PREVALENCE OF BARRETT'S ESOPHAGUS IN A RISK AREA FOR ESOPHAGEAL CANCER IN SOUTH OF BRAZIL.

DE Carli DM, Araujo AF, Fagundes RB.

Arq Gastroenterol. 2017 Dec;54(4):305-307. doi: 10.1590/s0004-2803.201700000-45. Epub 2017 Sep 21.

15.

Prevalence and predictors of columnar lined esophagus in gastroesophageal reflux disease (GERD) patients undergoing upper endoscopy.

Balasubramanian G, Singh M, Gupta N, Gaddam S, Giacchino M, Wani SB, Moloney B, Higbee AD, Rastogi A, Bansal A, Sharma P.

Am J Gastroenterol. 2012 Nov;107(11):1655-61. doi: 10.1038/ajg.2012.299. Epub 2012 Oct 2.

PMID:
23032983
16.

Development and Validation of a Model to Determine Risk of Progression of Barrett's Esophagus to Neoplasia.

Parasa S, Vennalaganti S, Gaddam S, Vennalaganti P, Young P, Gupta N, Thota P, Cash B, Mathur S, Sampliner R, Moawad F, Lieberman D, Bansal A, Kennedy KF, Vargo J, Falk G, Spaander M, Bruno M, Sharma P.

Gastroenterology. 2018 Apr;154(5):1282-1289.e2. doi: 10.1053/j.gastro.2017.12.009. Epub 2017 Dec 19.

PMID:
29273452
17.

A Tissue Systems Pathology Test Detects Abnormalities Associated with Prevalent High-Grade Dysplasia and Esophageal Cancer in Barrett's Esophagus.

Critchley-Thorne RJ, Davison JM, Prichard JW, Reese LM, Zhang Y, Repa K, Li J, Diehl DL, Jhala NC, Ginsberg GG, DeMarshall M, Foxwell T, Jobe BA, Zaidi AH, Duits LC, Bergman JJ, Rustgi A, Falk GW.

Cancer Epidemiol Biomarkers Prev. 2017 Feb;26(2):240-248. doi: 10.1158/1055-9965.EPI-16-0640. Epub 2016 Oct 11.

18.

Recent advances in oesophageal diseases.

Al Dulaimi D.

Gastroenterol Hepatol Bed Bench. 2014 Summer;7(3):186-9.

20.

Esophageal motor function in laryngopharyngeal reflux is superior to that in classic gastroesophageal reflux disease.

Postma GN, Tomek MS, Belafsky PC, Koufman JA.

Ann Otol Rhinol Laryngol. 2001 Dec;110(12):1114-6.

PMID:
11768699

Supplemental Content

Support Center